Fig. 2.

Receiver operator characteristic curve of CAP measurement for diagnosis of hepatic steatosis (>S0).

(A) Participants with mixed aetiologies of AILD: area under the ROC (AUROC) = 0.76. (B) Comparison of ROC to detect hepatic steatosis in participants with AIH (grey) and cholestatic liver disease (blue), AUROC differed significantly (AUROC AIH = 0.72; AUROC PBC/PSC = 0.88), p = 0.009. Differences of AUROC were calculated as proposed by Hanley and McNeil. AIH, autoimmune hepatitis; AILD, autoimmune/immune mediated liver diseases; PBC, primary biliary cholangitis; PSC, primary sclerosing cholangitis; ROC, receiver operator characteristic curve.